NetDragon Wins "Education Innovation & Technology- Rising Star Award" at the "2025 Hong Kong Sustainable Development Innovation and Technology Awards"
The '2025 Hong Kong Sustainable Development Innovation and Technology Awards' aim to honor organizations and talents across industries that integrate innovative technologies with sustainable development principles into the full spectrum of planning, application, and advancement of various solutions. In alignment with China's '14th Five-Year Plan' and the 'Hong Kong Innovation and Technology Development Blueprint,' this year's awards focused on three key pillars: economic, social, and environmental, covering nine areas including green finance and quality education, as well as cross-sector solutions such as achieving net-zero carbon emissions. More than 90 organizations submitted nearly 200 innovation and technology projects, with 12 categories of excellence ultimately selected. NetDragon was honored with the 'Rising Star Award' in the Quality Education Innovation Technology category for its innovation and impact in promoting sustainable digital education.
As a pioneer in EdTech, NetDragon remains committed to its mission of 'empowering education through technology.' By integrating cutting-edge technologies such as AI, VR, AR, and the metaverse, the Company has created a global digital education ecosystem to deliver high-quality learning resources and promote equitable, inclusive education worldwide. Through its partnership with UNESCO's Institute for Information Technologies in Education (UNESCO IITE), NetDragon launched the " E-Library For Teachers " platform, providing educators worldwide with high-quality teaching resources and AI-powered solutions, significantly enhancing accessibility and equity in education. Internationally, NetDragon has also collaborated with Thailand's Ministry of Higher Education, Science, Research, and Innovation (MHESI) to introduce the AI education platform " MHESI Skill,' demonstrating its growing global influence. By building a comprehensive EdTech ecosystem that integrates hardware, software, platforms, and resources, NetDragon is lowering barriers to access, improving teaching efficiency and student engagement, and advancing equitable education worldwide. Currently, NetDragon's digital products are used in over 2 million classrooms across 192 countries.
Winning the 'Education Innovation & Technology - Rising Star Award' not only affirms NetDragon's strength in educational technology innovation but also underscores its ongoing commitment to sustainability. Looking ahead, NetDragon will continue to expand the boundaries of EdTech innovation, integrate ESG principles across its operations and offerings, and advance global education equity and technology inclusion. NetDragon remains dedicated to contributing to global progress toward the United Nations' '2030 Sustainable Development Goals (SDGs),' creating a more inclusive and sustainable future.
About NetDragon Websoft Holdings Limited
NetDragon Websoft Holdings Limited (HKSE: 0777) is a global leader in building internet communities with a long track record of developing and scaling multiple internet and mobile platforms that impact hundreds of millions of users, including previous establishments of China's first online gaming portal, 17173.com, and China's most influential smartphone app store platform, 91 Wireless.
Established in 1999, NetDragon is one of the most reputable and well-known online game developers in China with a history of successful game titles including Eudemons Online, Heroes Evolved, Conquer Online, and Under Oath. In the past 10 years, NetDragon has also achieved success with its online education business both domestically and globally, and its overseas education business entity, currently a U.S.-listed subsidiary named Mynd.ai, is a global leader in interactive technology and its award-winning interactive displays and software can be found in more than 1 million learning and training spaces across 126 countries.
For investor enquiries, please contact:
NetDragon Websoft Holdings Limited
Ms. Maggie Zhou
Senior Director of Investor Relations
Email: [email protected] / [email protected]
Website: ir.netdragon.com
View original content to download multimedia: https://www.prnewswire.com/news-releases/netdragon-wins-education-innovation--technology-rising-star-award-at-the-2025-hong-kong-sustainable-development-innovation-and-technology-awards-302498634.html
SOURCE NetDragon Websoft Holdings Limited
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Bloomberg
39 minutes ago
- Bloomberg
Why Jane Street Was a Target in India's Option Trading Crackdown
India has gone from being a small player in the highly speculative equity derivatives market to the world's largest, all within just five years. Daily turnover in the market now sits at around $3 trillion. Demand for so-called equity options in particular has exploded as large numbers of relatively inexperienced retail investors came in search of quick returns. There are concerns that some large market participants have been using sophisticated technology to manipulate the system to their advantage. A study by the Securities and Exchange Board of India found that retail investors lost more than $20 billion on option trades over three years.
Associated Press
44 minutes ago
- Associated Press
National Taiwan Normal University Opens Nominations for 15th President
TAIPEI, TAIWAN - Media OutReach Newswire - 7 July 2025 - National Taiwan Normal University (NTNU), one of Taiwan's most prestigious public universities, has announced a call for public nominations for its 15th President. The nomination period runs from July 7 to August 11, 2025. NTNU has announced a call for public nominations for its 15th President. The nomination period runs from July 7 to August 11, 2025. President Cheng-Chih Wu will conclude his term on February 21, 2026. In line with institutional regulations, the Presidential Selection Committee has been formally convened and is now publicly soliciting nominations from all sectors. With over a century of academic excellence, NTNU has grown into a comprehensive and internationally recognized university. In the latest QS World University Rankings by Subject, six of its disciplines were ranked among the global top 100— the second highest among Taiwanese universities. The total number of ranked subjects increased from 12 last year to 18, covering education, engineering, management, the humanities, and the basic sciences. The university is recognized for its diverse and internationalized campus. NTNU recently signed cooperation agreements with renowned institutions such as Columbia University, the University of Texas at Austin, and Osaka University. In November 2023, the Ministry of Education designated NTNU as a Bilingual Benchmark University. With nearly 1,000 English-taught courses offered annually, NTNU currently enrolls 1,722 international degree-seeking students from 64 countries, representing 12.05% of its student body—the highest proportion among Taiwan's national universities. NTNU maintains strong partnerships with leading industries and cultural institutions, including TSMC, NVIDIA, Realtek Semiconductor, the National Palace Museum, and Longshan Temple. In 2023, it established the Graduate Institute of AI Interdisciplinary Applied Technology and the Graduate Institute of Green Energy and Sustainable Technology within the newly established College of Industry-Academia Innovation, which celebrated its first graduating class this year. Committed to pedagogical innovation, NTNU has launched an Interdisciplinary Bachelor's Program and established an Interdisciplinary Academic Advisory Office to encourage students to pursue interdisciplinary, interdepartmental, intercollegiate, and international coursework. In 2024, the university expanded its summer offerings resulting in over 2,600 enrollments across more than 100 courses, which support flexible and self-directed learning. The new president will lead NTNU in its ongoing pursuit of academic excellence and global engagement, steering the university toward its strategic vision of becoming a leading institution in Asia with global distinction. Key responsibilities include advancing interdisciplinary integration, expanding international partnerships, and enhancing NTNU's societal impact. At its second meeting, the Presidential Selection Committee approved the eligibility criteria and selection procedures. Candidates must meet the appointment requirements outlined in the Act Governing the Appointment of Educators and other applicable laws. Additionally, they must be under 65 years of age as of February 22, 2026, and possess the following qualifications: 1. Recognized academic achievements and distinguished reputation 2. Exemplary moral character and integrity 3. Demonstrated excellence in administrative leadership 4. A clear and visionary philosophy for higher education 5. Proven ability to secure and effectively manage institutional resources Nominations may be submitted through one of the following five channels: 1. A joint nomination by at least three Academicians of Academia Sinica 2. A joint nomination by at least ten professors or scholars of equivalent academic standing at domestic or international institutions 3. A nomination by a professional academic organization officially recognized by the Ministry of the Interior 4. A joint nomination by at least thirty NTNU alumni 5. A nomination by formal resolution of the NTNU Student Association The nomination period will remain open from July 7 to August 11, 2025. Individuals and organizations from all sectors are encouraged to nominate outstanding candidates. Candidates will be invited to present their vision and engage with the university community at a public forum scheduled for early October 2025. A university-wide recommendation vote will follow in mid-October, with the Presidential Selection Committee making the final decision later that month. The new President will assume office on February 22, 2026. For detailed information on the nomination process, eligibility criteria, and downloadable forms, please visit the official NTNU Presidential Selection website: Hashtag: #NTNU The issuer is solely responsible for the content of this announcement.
Associated Press
44 minutes ago
- Associated Press
ChiMei Medical Center adopts Inocras MRDVision and WGS bioinformatics platform for precision oncology in Taiwan
SAN DIEGO & TAINAN CITY, Taiwan--(BUSINESS WIRE)--Jul 7, 2025-- Inocras Inc., a global leader in whole-genome sequencing (WGS) and bioinformatics, today announced the signing of a Memorandum of Understanding (MOU) with ChiMei Medical Center (CMMC), a premier medical institution in Taiwan, and Trivator Biomedical Limited, a biomedical advisory firm in Taiwan. This expansion agreement aims to introduce Inocras's MRDVision tumor-informed minimal residual disease (MRD) test, utilizing circulating tumor DNA (ctDNA) blood samples, and CancerVision, its AI-powered bioinformatics cloud solution, to support WGS at CMMC, advancing Taiwan's precision oncology landscape. This initiative brings together CMMC's in-house WGS laboratory infrastructure with Inocras's advanced bioinformatics and ctDNA analysis platforms, creating a synergistic ecosystem for both research and clinical-grade genomics. The integration of MRDVision's ultra-sensitive ctDNA monitoring with CancerVision's scalable cloud analytics enables an end-to-end workflow—from sequencing to interpretation—within CMMC's existing clinical operations. CancerVision, Inocras's whole-genome tumor profiling test, forms the foundation for tumor-informed MRD analysis by first characterizing each patient's tumor genome. This enables the application of MRDVision, which monitors circulating tumor DNA (ctDNA) across the entire genome with a simulated limit of detection of 1 part per million (ppm), without requiring patient-specific panels. Powered by Ultima Genomics' ppmSeq technology and Inocras's bioinformatics platform, MRDVision identified tumor signals in 6% of cases missed by a leading MRD assay in a head-to-head clinical study of post-surgical ovarian and lung cancer patients. Integrated into CMMC's sequencing and clinical workflows, CancerVision and MRDVision together provide an end-to-end solution for genome-informed cancer monitoring and personalized treatment assessment. 'We are excited to partner with ChiMei Medical Center and Trivator to bring MRDVision and our CancerVision bioinformatics cloud solution to Taiwan,' said Jehee Suh, CEO of Inocras Inc. 'MRDVision's unmatched sensitivity, combined with CancerVision's robust cloud-based analytics, will empower CMMC to deliver cutting-edge cancer monitoring and precision medicine to patients.' Chi Mei Medical Center, renowned for its leadership in innovative healthcare, will leverage its clinical expertise and advanced infrastructure to implement the MRDVision and CancerVision platforms, further enhancing its whole-genome sequencing (WGS) capabilities. Trivator Biomedical Limited will provide local advisory and logistical support to ensure seamless integration into Taiwan's routine medical practice. 'We are proud to be a regional pioneer in integrating genomic technologies into routine oncology practice,' said Dr. Chein-Feng Li, Director of the Core Laboratory for Precision Medicine at Chi Mei Medical Center. 'By incorporating Inocras's MRDVision and CancerVision platforms, we are strengthening our capabilities in personalized cancer diagnostics and advancing Taiwan's leadership in translational genomic medicine.' 'This collaboration is a transformative step for precision medicine in Taiwan,' said Wen-Tsao Lee, founder of Trivator Biomedical Limited. 'By introducing MRDVision and CancerVision, we are combining Inocras's innovative technologies with CMMC's clinical excellence to redefine cancer care and genomic research.' The MOU serves as a framework for future definitive agreements to scope collaborative projects. The parties are committed to assessing market feasibility, engaging key opinion leaders, and establishing Taiwan as a hub for WGS-based precision medicine, with a focus on MRDVision and CancerVision. For more information about Inocras and its precision medicine solutions, visit View source version on CONTACT: Media Contact Inocras Inc. Gordon Cheung Email:[email protected] Phone: +852-3511-6347ChiMei Medical Center Chein Feng Li Email:[email protected] Phone: +886-6-281-2811 Ext 53680Trivator Biomedical Limited Wen-Tsao Lee Email:[email protected] Phone: +886-955-817-357 KEYWORD: NORTH AMERICA UNITED STATES SOUTH KOREA ASIA PACIFIC TAIWAN CALIFORNIA INDUSTRY KEYWORD: ONCOLOGY HEALTH HEALTH TECHNOLOGY GENETICS RESEARCH SCIENCE BIOTECHNOLOGY SOURCE: Inocras Inc. Copyright Business Wire 2025. PUB: 07/07/2025 10:31 AM/DISC: 07/07/2025 10:32 AM
